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WE investigated the effects of the antibiotic cefta-
zidime (C2LZ) on the cytolytic action of the neu-
trophil myeloperoxidase-hydrogen peroxide-
chloride anion system (MPO/H202/CI-). In this
system, myeloperoxidase catalyses the conver-
sion of H202 and CI- to the cytotoxic agent HOCI.
Stimulated neutrophils can release MPO into the
extracellular environment and then may cause
tissue injury through direct endothelial cells lysis.
We showed that human umbilical vein endothe-
lial cells (ItUVEC) were capable of taking up
active MPO. In presence of H202 (10-4M), this
uptake was accompanied by cell lysis. The cyto-
lysis was estimated by the release of SlCr from
HUVEC and expressed as an index of cytotoxicity
(IC). Dose dependent protection was obtained for
CAZ concentrations ranging from 10- s to 10- 3M;
this can be attributed to inactivation of HOCI by
the drug. This protection is comparable to that
obtained with methionine and histidine, both of
which are known to neutralize HOCI. This protec-
tion by CAZ could also be attributed to inactiva-
tion of H202, but when cytolysis was achieved
with H202 or 02- generating enzymatic systems,
no protection by CAZ was observed. Moreover,
the peroxidation activity of MPO (action on
H202) was not affected by CAZ, while CAZ pre-
vented the chlorination activity of MPO (chlor-
ination of monochlorodimedon). So, we
concluded that CAZ acts via HOCI inactivation.
These antioxidant properties of CAZ may be
clinically useful in pathological situations where
excessive activation of neutrophils occurs, such
as in sepsis.
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Introduction
Sepsis, septic shock, severe trauma, hypovo-
laemic shock and acute pancreatitis are examples
of severe pathological situations accompanied by
an intense inflammatory reaction involving activa-
tion of specific cells and release of mediators.
This inflammatory reaction occasionally over-
whelms the organism’s defences, with excessive
activation of polymorphonuclear leucocytes
(PMN). This can lead to the systemic inflamma-
tory response syndrome (SIRS) and eventually to
multiple organ dysfunction syndrome (MODS).- PMN activation produces activated oxygen species
(mainly superoxide anion and hydrogen per-
oxide, H202) inflammatory mediators, and pro-
teolytic and hydrolytic enzymes.4’5 PMN also
release myeloperoxidase (MPO) from their gran-
ules; in the presence of H202 and chloride anion
(Cl-), MPO generates hypochlorous acid
(HOC1). HOC1 reacts with amines to form chlor-
amines, but also with H202 itself to produce
singlet oxygen, an activated form of oxygen.<7
These activated oxygen species and oxidant pro-
ducts of MPO activity normally play a beneficial
role in host defence against invading microorgan-
isms. However, their excessive production can be
detrimental for tissues, especially for endothelial
cells, such as, when PMN are trapped in capil-
laries and become strongly adherent to endothe-
lium.
8 They are also destructive for plasma
proteins, especially those with thiol (-SH) func-
tions, such as (x2 macroglobulin, an essential plas-
matic antiproteinase.
9- In these situations
associated with excessive activation of PMN, ther-
apeutic agents capable of neutralizing these active
oxygen species and protecting endothelial cells
from oxidant stress would have potential clinical
utility. Recent research has demonstrated that
antibiotic molecules of the aminoglycoside and
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cephalosporin families can protect epithelial cells
submitted to an oxidant stress, and are sca-
vengers for HOCl molecules.12-14
We have demonstrated that the antibiotic cef-
tazidime (CAZ), which belongs to the cephalos-
porin family, exerts an antioxidant effect in vitro.
it inhibits perferryl mediated lipoperoxidation by
iron scavenging, neutralizes HOCl, and quenches
singlet oxygen.
15-17 The purpose of this study
was to demonstrate that CAZ is able to protect
endothelial cells from the oxidant stress induced
by the activity of MPO or by HOCl. In our study,
CAZ was used as a model of broad spectrum ]3-
lactarnase resistant antibiotics, which are widely
used in clinical situations of severe sepsis, as
mentioned above; these are precisely the situa-
tions wherein intense PMN activation is seen.
Materials and Methods
Cell culture.. Human umbilical vein endothelial
cells (HUVEC) were isolated by collagenase
treatment of umbilical cords according to Jaffe et
aL
8 HUVEC were cultured on 0.2% gelatine
coated dishes in M199 medium supplemented
with 10% heat-inactivated foetal calf serum
(Gibco), 5% heat-inactivated human serum
(Sigma), penicillin (100 U/ml), streptomycin
(100 btg/ml), heparin (90 btg/ml) and endothelial
cell growth factor (Boehringer-Manheim)
(201.tg/ml). Adherent HUVEC in six multiwell
plates (passage 2) were used in all experiments.
Assay for MPO enzyme activRy: MPO was pur-
ified from human polymorphonuclear neu-
trophils as described previously.9’2 Its enzyme
activity was determined by spectrophotometric
methods.
MPO peroxidative activity. MPO peroxidative
activity was assayed by measuring the absorbance
increase at 460nm caused by the oxidation of
ortho-dianisidine.
2 MPO (dissolved in 50 I.tl) was
added to 3 ml of 50mM ortho-dianisidine in S6r-
ensen buffer pH 5.5 and the reaction was started
by the addition of H202 at a final concentration
of 0.15 mM. The absorbance increase at 460nm
was followed for 1 min. One unit of activity was
defined as the amount of MPO which produced
an absorbance increase of 1 optical density unit
per minute.
MPO-dependent chlorination activity. MPO-
dependent chlorination activity was measured by
following the conversion of monochlorodimedon
to dichlorodimedon at 290nm.
22 Typical experi-
mental conditions were as follows: MPO (5/.tg)
was incubated in 3ml of monochlorodimedon
(24btM) in 100mM phosphate buffer (pH 5.5)
with NaCl (50mM) added. The reaction was
started by the addition of H202 (0.1 mM) and the
decrease of absorbance at 290nm was followed
for 1 min. One unit of activity was defined as the
amount of MPO which produced an absorbance
decrease of 1 optical density unit per minute.
To determine the effects of CAZ on MPO
enzyme activities, MPO was incubated with differ-
ent concentrations of CAZ for 5 min at room
temperature before the enzyme assays. The data
represent arithmetic means ___
S.D. of triplicates.
MPO uptake by HUVEC. Confluent cells in 1 ml
of Hanks’ Balanced Salt Solution (HBSS)were
incubated at 37C with increasing amounts of
MPO (from 0 to 30 l.tg) for 3 h or with a fixed
amount of MPO (5t.tg) for periods of time
ranging from 0 to 360 min. Each assay was done
in triplicate and the entire experiment was repe-
ated three times. After these incubations, cells
were washed three times with HBSS, and the
MPO content of the cells was estimated by mea-
surement of MPO peroxidative activity (see
above). Ortho-dianisidine (lml) was added to
adherent cells and the reaction was started by
the addition of H202 at a final concentration of
0.15 mM. After an incubation of 30 min, the reac-
tion buffer was collected and the absorbance at
460nm was read. The amount of MPO present in
the cells was calculated from a standard curve for
which known amounts of MPO were incubated
under the same conditions.
Cytotoxiiy assay: Cytotoxicity was assessed by
measuring the release of previously incorporated
51Cr.23 Confluent HUVEC in six multiwell plates
were labelled overnight by the addition of 20 btCi
5Cr in culture medium per well (sodium chro-
mate, Amersham). HUVEC were washed in HBSS
to remove unincorporated 51Cr and the cells
were then submitted to oxidant stress as descri-
bed below. Each assay was done in triplicate. At
the end of the oxidant stress period, the super-
natants were collected and the cells were washed
three times with HBSS. Supernatant and washings
were pooled and 51Cr release JR] was quantified
by 7 counting.
Cells were lysed in NaOH (1 N) and the intra-
cellular 5Cr [I] was counted. The percentage of
5Cr release [PR] was calculated for each test
condition as follows:
R
PR x 100
R+I
Where R + I is the total amount of 5Cr present
in the cells before the application of the oxidant
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stress. An index of cytotoxicity [IC] was calcu-
lated according to the following formula: 0.8-
IC 100 x 0.6
100- [PR]cont
where [PR] cont represents the spontaneous
release of 51Cr (in percent as above) by the
o.4
control cells incubated in HBSS alone.
Oxidant stress against HUVEC: Four oxidant
stressors were used against HUVEC. For each
oxidant stress assay, controls were performed in
which HUVEC were incubated under the same
conditions in HBSS alone; each assay was done
in triplicate.
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FIG. 1. Kinetics of MPO uptake by HUVEC (4 x 10 ceils). Con-
Cytotoxicity induced by the MPO/HeOe/C1- fluent HUVEC were incubated with 5btg of MPO. After cell
washings, MPO uptake was estimated by the ortho-dianisidine system. HUVEC in i ml of HBSS were incubated assay (see text). Data represent arithmetic mean Jr S.D. of tripli-
in the presence of MPO (5lag) at 37C for 2h. cates.
The C1- required for MPO enzyme activity was
supplied by HBSS. H202 (10-4M) was added to
initiate MPO enzyme activity and after a further
2h incubation at 37C, IC was determined as
described before.
% protection 100 x (
ICeff ) ICstress
Cytotoxicity induced by sodium hypochlorite where ICeff and ICstress were, respectively, the IC
(NaOCI). NaOCl (10-M)was added to HUVEC obtained in the presence or in the absence of
in I ml of HBSS. After a 2 h incubation, IC was the study drug.
evaluated.
Results Cytotoxicity induced by the glucose
oxidase system. HUVEC in l ml HBSS (containing MPO uptake by HUVEC: The results for the
5mM of glucose) were incubated overnight with kinetics of MPO uptake are presented in Fig. 1.
glucose oxidase (0.2 U) (Boehringer-Manheim) MPO was quickly taken up by HUVEC; after only
prior to IC evaluation. 15 min of incubation 0.177 +__ 0.037 lag of MPO
were already present in the cells. The maximal
Cytotoxicity induced by the xanthine/xanthine uptake reached a plateau after 180 min, with
oxidase system. HUVEC in l ml of HBSS were 0.553_ 0.0121.tg taken up. This maximal value
treated with 2mM xanthine/20mU of xanthine corresponds to an uptake of 11.00 _-+ 0.24% of
oxidase (Boehringer-Manheim) for 2 h following added MPO.
which ICwas determined. The dose-response curve of MPO uptake by
HUVEC is shown in Fig. 2. The uptake of MPO
Protection from oxidant stress.. The effects of reached a plateau for a MPO dose of 7.5 l.tg of
CAZ on oxidant stress were compared to MPO. At this dose, 0.585 _
0.018 I.tg of MPO was
methionine, histidine and dabco (1,4-diazabicy- taken up by the HUVEC; this corresponded to an
clo [2.2.2] octane), Which are well known HOCl uptake of 7.80 0.24% of added MPO.
24 25 and O2 scavengers. 5Cr labelled HUVEC in
l ml of HBSS supplemented with one of the Cytotoxiciy of the MPO/HeOe/C1- system on
putative protectors (CAZ, methionine, histidine HUVEC.. When HUVEC were incubated for 2h
or dabco) were incubated for 2h prior to initi- with MPO (51.tg) and H202 (10-4M) added
ating the cytotoxic treatments described above, simultaneously, only a low cytotoxicity
For the oxidant stress with MPO/H202/CI-, the (IC 5.04 __. 2.1)was found. No cytotoxicity was
protector was added with MPO 2h before the obtained with either MPO or H202 alone. To
addition of H202 After the stress, IC was deter- permit the uptake of MPO prior to initiating the
mined, and the % protection was obtained oxidant stress with H202, the cells were pre-
according to the following formula: incubated with MPO for 2h. This time of pre-
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FIG. 2. Dose-response curve of MPO uptake by HUVEC
(4 x 10 cells). Adherent HUVEC were incubated for 3 h at 37C
with increasing amounts of MPO (0 to 30lag). After cell wash-
ings, MPO uptake was estimated by the ortho-dianisidine assay
(see text). Data represent arithmetic mean ___
S.D. of triplicates.
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FIG. 4. Protection of HUVEC from MPO/H202/CI- stress. Com-
parison of ceftazidime (CAZ) with methionine, histidine and
dabco. 51Cr labelled HUVEC were preincubated with MPO (51g)
and variable concentrations of the protectors for 2 h at 37C: I-I,
CAZ; I!, methionine; [], histidine;., dabco. H202 (10-4M)
was added to initiate stress and the % protection was calculated
after 2 h. The results are expressed as arithmetic mean ___
S.D.
of three experiments performed in triplicate. *No statistical differ-
ence (p > 0.05) and **statistical difference (p < 0.05) vs. stress
without protector when analysed with the two-tailed Student’s
t-test.
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FIG. 3. Dose-response of MPO cytotoxicity on HUVEC. Confluent
HUVEC were preincubated with increasing doses of MPO for 2 h.
Oxidant stress was then induced by addition of H202 and the
cytotoxicity index (IC) was determined after 2 h incubation (see
text). Data represent mean +__ S.D. of triplicates.
incubation was chosen because after 2h MPO
uptake was near its maximal value, but still on
the linear part of the curve of Fig. 1. After addi-
tion of H202 (10-4M), a further incubation of
2h with the complete cytotoxic system (MPO/
H202/C1-) was performed. After this time of
incubation, convenient and reproducible IC were
obtained. For shorter times of incubation, we
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measured low IC values, insufficient to allow
reproducible assays of putative protective sub-
stances.
Figure 3 plots the dose-response effect of
MPO on HUVEC cytotoxicity: a plateau was
reached at 5btg MPO (with a maximal
IC 39.92 0.64).
Protection of HUVEC from MPO/H202/CI- or
NaOCI oxidant stresses: To test the effects of
putative protectors (CAZ, methionine, histidine,
or dabco), the protector was added at different
concentrations on HUVEC, together with 5 t.tg of
MPO, and the cells were incubated for 2 h prior
to addition of H202 (Fig. 4). We controlled the
effects of CAZ on MPO uptake by endothelial
ceils and found neither inhibiting nor enhancing
effects of the antibiotic: without CAZ, we found
an uptake of 0.476 _+ 0.0441Ltg MPO, and with
CAZ (10-M), an uptake of 0.469 +__ 0.011btg
(no statistical difference). After the stress, IC was
calculated and the results were expressed as
percent protection according to the formula
defined in Materials and Methods: a protection of
100% corresponds to a total inhibition of stress-
induced cytotoxicity.
The protection by CAZ was dose-dependent
and articularly effective at the concentration of
10-M (percent protection 92.4 ___
1.7). This
protection was confirmed by light microscope
observations, which indicated a similar cellular
aspect for control cells (without stress) and cellsCefiazidime protects towards oxidant stress
Table 1. CAZ protection of HUVEC from NaOCI
stress. Comparison with methionine and histidine
Protector % protection
CAZ (10-3M) 77.90 4- 11.50
Methionine (10-
3 M) 91.38 _+ 5.20
Histidine (10-3M) 20.18 4- 12.00
The data represent mean -I- S.D. of three experiments
performed in triplicate
stressed in the presence of CAZ 10-3M, while
the cells stressed in the absence of CAZ
appeared strongly damaged (loss of most of the
cells and strong morphologic changes). At a CAZ
concentration of 10-5M, a protective effect was
still observed (percent protection 26.0 4- 0.9).
Methionine and CAZ demonstrated comparable
protective effects (no statistically significant dif-
100
8O
: 60
2O
10
-4 2.5 x 10
--4 5 X 10
-4 10-3 M [CAZ]
ference between the two compounds), but histi- FIG. 5. Effects of CAZ on MPO enzyme activities. MPO was pre-
incubated with different concentrations of CAZ for 5 min at dine was less effective (p < 0.05 for each room temperature. I-I, peroxidative activity of MPO; N, chlorina-
concentration compared to CAZ and methio- tion activity of MPO. MPO enzyme activities obtained in the
nine). In contrast, no protection was obtained absence of CAZ were taken as the reference (100%). Each point
represents the mean 4- S.D. of two experiments performed in with dabco (percent protection 6.6 -t- 9.0). triplicate. *No statistical difference (p > 0.05)and **statistical dif-
From these results, we concluded that CAZ ference (p < 0.05) vs. control when analysed with the two-tailed
was capable of neutralizing cytotoxicity induced Student’s t-test.
by the MPO/H202/CI- system by inactivating the
HOC1 generated by MPO. To confirm the direct
effect of CAZ on NaOC1, 5aCr labelled HUVEC Effects ofCAZ on MPO enzyme activities.. Even at
were exposed to NaOC1 stress in presence of concentrations of CAZ (10-3M) which were
CAZ, methionine, or histidine; the cells were highly protective for HUVEC submitted to MPO/
incubated at 37C for 2h in the presence of H202/CI- stress, only weak inhibition of MPO
putative protector (at a concentration of peroxidative activity was observed (90.0 -t- 0.7%
10- 3 M). NaOC1 (10- 3 M) was then added and of control activity) (Fig. 5). In contrast, MPO-
the IC was determined after a further 2 h incuba- dependent chlorination of monochlorimedon
tion. The IC in the absence of protector was was very sensitive to CAZ: no chlorination was
14.86-t-3.15 and the percent protection, calcu- observed in the presence of 5 x 10-4M and
lated as previously described, are presented in only 61.0 -t- 4.9% of activity was conserved in the
Table 1. Marked protection was seen with CAZ presence of 2.5 x 10-4M CAZ.
and methionine, while histidine was weakly
active. Discussion
Absence of a protective effect of CAZ on oxidant In this study we demonstrate that endothelial
stress generating He02: To test the effect of CAZ cells are capable of binding and taking up mye-
on HUVEC cytotoxicity induced by RiO2 or O2-, loperoxidase. This uptake shows steep time
we incubated the cells in the presence of enzy- dependency at 37C, and is maximal at 3 h incu-
matic systems generating this reactive oxygen bation. The yield of the uptake process is low,
species: glucose/glucose oxidase or xanthine/ with a maximum incorporation of 11% when
xanthine oxidase systems. 5 lag of MPO are added to the culture medium
For the two stresses, no statistically significant (Fig. 1). Increasing the amount of MPO added to
difference was observed (two-tailed Student’s the medium does not increase uptake, which
test) between the cytotoxicity obtained in the peaks at 7.5lag (62.4nM) added MPO. At this
absence or in the presence of CAZ (10-M). level, 7.8% of the added dose is incorporated
The IC values obtained for glucose/glucose after 3h incubation. These results agree with
oxidase stress were respectively 25.02 ___
3.91 those of Zabucchi et al.26 who show that 75% of
without CAZ and 25.93 +__ 5.26 with CAZ. For endothelial cells have a positive cytochemical
xanthine/xanthine oxidase stress the IC values peroxidase reaction after preincubation with high
were 76.98 +_ 0.49 without CAZ and 78.37 +__ 2.31 concentrations of MPO (up to 420 nM). These
with CAZ. workers also showed that the enzyme was
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present on the cell membrane and in the cyto-
plasm. Using the same cytochemical reaction, we
showed uptake of MPO by endothelial cells, and
its presence in intracellular granules (results not
shown). Spectrophotometric measurement of
intracellular enzymatic activity confirmed uptake
and showed that the internalized enzyme
retained its activity. We used lower concentra-
tions of MPO than Zabucchi et al., but in our
study, we used a 3 h incubation (as opposed to
the 10 min used by Zabucchi’s group). This
duration of incubation did not alter the enzyme,
because at the end of the period, the sum of
enzyme left in the supernatant and that incorpo-
rated into the cells exactly equalled the total initi-
ally added.
In the presence of H202, MPO produces a
cytolytic oxidative stress on endothelial cells,
which we have expressed as a cytotoxicity index.
This IC increases linearly with the dose of MPO
with a plateau at 5 btg per 4 x 105 cells. No cyto-
toxicity is observed, however, if MPO is not pre-
incubated with the cells prior to addition of
H202 This indicates that incorporation of the
enzyme (or its absorption to the cell surface) is
necessary. In subsequent experiments of the pro-
tective effects of added substances, we used a
concentration of 5g for 4 x 105 cells. We chose
a 2 h pre-incubation at 37C, because this timing
allowed reproducible uptake across batches of
cells. After addition of H202, a further 2 h incu-
bation was chosen because this timing allowed a
convenient and reproducible cytotoxicity.
Several antibiotics have been reported to have
antioxidant properties against active forms of
oxygen.14’27-29 We chose to use ceftazidime
because it is a highly effective agent, a broad-
spectrum ]3-1actamase resistant antibiotic with
anti-Pseudomonas activity, widely used in patients
in the intensive care unit. CAZ protects endothe-
lial cells from the oxidant stress induced by MPO
in a dose dependent fashion, comparably to
methionine, and more powerfully than histidine.
These two amino acids are capable of scavenging
HOCl, formed by the enzyme action of MPO in
the presence of H202 and el-.4’5 The protective
effect of CAZ could thus be attributed to its reac-
tion with HOCl, neutralizing the oxidant activity
responsible for the cytolysis seen in our experi-
mental model. This mode of action is confirmed
by the observation of a protective effect of CAZ
on endothelial cells against direct attack by
added NaOC1. This protection is less than that of
methionine, but superior to that of histidine. This
latter compound is less active on NaOC1 stress
than on MPO/H202/Cl- stress. This can be
explained by the differences in the two types of
stress. In the first case, the concentration of
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HOCl directly reaches 10-M. The activity of
MPO induces a progressive release of low con-
centrations of HOC1, without reaching a final
concentration of 10-3M. The reaction of CAZ
with HOCl occurs simultaneously with its forma-
tion by MPO, and prevents its chlorination of
monochlorodimedon. On the other hand, CAZ
has no effect on the peroxidase activity of MPO.
The reaction of CAZ with HOCl could occur at
either thioether groups or near amine groups of
the antibiotic. It should be noted, however, that
according to Lapenna et al.,
4 the reaction of
CAZ with HOCl does not lead to formation of
chloramines, which pleads against involvement of
amine groups. The protective effect of methio-
nine confirms a role of sulfur atoms, while histi-
dine’s action can only be explained by the
presence of nitrogen, with the formation of non-
toxic chloramines. The lack of a sulfur atom in
histidine could partially explain the lower protec-
tive effect of this compound compared to CAZ
and methionine.
In our model, neutralization of HOCl by CAZ
is the principal mode of action of the antibiotic.
The simultaneous presence of H202 and HOC1
during the activity of MPO could lead to the for-
mation of singlet oxygen (O2), a highly reactive
30 32 species. We have previously shown that CAZ
is capable of interacting with O2, deactivating it
more powerfully_ than dabco, a well-characterized
quencher.5-7’25 Under our experimental condi-
tions, dabco at a concentration of 10-M was
only weakly protective. This would seem to indi-
cate that singlet oxygen is not the principal
source of oxidant stress on endothelial cells
induced by the activity of MPO. On the other
hand, the lack of efficacy of CAZ against oxidant
stress induced by glucose oxidase, and especially
xanthine oxidase, which both produce super-
oxide anion and H202, indicates that the anti-
biotic does not act directly on these two
activated species of oxygen, what has been
already demonstrated for other antibiotics.
Cantin et al. described similar cytotoxicity of
the MPO/H202/Cl- system against epithelial
cells, using 2.5 l.tg/ml MPO, and observed a pro-
tective effect of CAZ at concentrations approxi-
mately equal to those we used. Ottonello et al.
2
showed protection by several antibiotics, includ-
ing CAZ, against the action of stimulated PMN on
lymphoblastoid cells (Daudi cell line), and attrib-
uted this effect to inactivation of HOCl produced
extracellularly by MPO. Preliminary results from
our laboratory suggest that CAZ also protects
endothelial cells from the cytolytic activity of acti-
vated PMN.
We thus see that CAZ, in addition to its anti-
biotic activity possesses antioxidant properties.Cefiazidime protects towards oxidant stress
These could be useful in situations where exces-
sive PMN activation, production of activated
species of oxygen, and liberation of MPO are
seen. Sepsis and septic shock are two such situa-
tions. In our model, the lowest concentration
associated with a protective effect (10-5M
5.461.tg/ml, 26% protection) is inferior to the
serum concentrations attained in patients treated
with this antibiotic: following an intravenous
infusion of 2g CAZ in healthy volunteers and
patients, the serum concentration peaks at 59 to
83btg/ml.34 The combination of an antioxidant
activity with those of an antibiotic in one mole-
cule allows simultaneous treatment with a well
characterized, widely used drug, of both the
infectious aspect of the disease process, as well
as the consequences of excessive PMN activation.
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